Back to Search
Start Over
Oxford COVID-vaccine paper highlights lingering unknowns about results
- Source :
- Nature. December 17, 2020, Vol. 588 Issue 7838, p378, 2 p.
- Publication Year :
- 2020
-
Abstract
- The Oxford-AstraZeneca partnership is the first major developer to publish detailed data from phase III trials. The Oxford-AstraZeneca partnership is the first major developer to publish detailed data from phase III trials.<br />Author(s): Heidi Ledford Author Affiliations: Oxford COVID-vaccine paper highlights lingering unknowns about results The results suggest that the Oxford-AstraZeneca vaccine is safe and effective. Credit: Juan Mabromata/AFP/Getty A scientist working [...]
- Subjects :
- AstraZeneca PLC -- Product development -- Research agreements
Pharmaceutical industry -- Product development -- Research agreements
Environmental issues
Science and technology
Zoology and wildlife conservation
University of Oxford -- Reports -- Research agreements
AZD1222 (Vaccine) -- Product development -- Safety and security measures -- Testing
Subjects
Details
- Language :
- English
- ISSN :
- 00280836
- Volume :
- 588
- Issue :
- 7838
- Database :
- Gale General OneFile
- Journal :
- Nature
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.649629267
- Full Text :
- https://doi.org/10.1038/d41586-020-03504-w